thiazoles has been researched along with Colitis-Associated Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, D; Wang, L; Xie, B; Xie, L | 1 |
1 other study(ies) available for thiazoles and Colitis-Associated Cancer
| Article | Year |
|---|---|
Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells.
Topics: Animals; Colitis-Associated Neoplasms; Cytokines; Mice; Myeloid Differentiation Factor 88; Myeloid-Derived Suppressor Cells; Piperazines; Signal Transduction; Thiazoles; Tumor Microenvironment | 2022 |